These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1447732)

  • 1. Cysteine protease inhibition by azapeptide esters.
    Magrath J; Abeles RH
    J Med Chem; 1992 Nov; 35(23):4279-83. PubMed ID: 1447732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
    Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
    Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases.
    Kato D; Verhelst SH; Sexton KB; Bogyo M
    Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
    Löser R; Frizler M; Schilling K; Gütschow M
    Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
    [No Abstract]   [Full Text] [Related]  

  • 6. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
    Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
    Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
    Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
    J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases.
    Demuth HU; Schierhorn A; Bryan P; Höfke R; Kirschke H; Brömme D
    Biochim Biophys Acta; 1996 Jul; 1295(2):179-86. PubMed ID: 8695644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.
    Darkins P; Gilmore BF; Hawthorne SJ; Healy A; Moncrieff H; McCarthy N; McKervey MA; Brömme D; Pagano M; Walker B
    Chem Biol Drug Des; 2007 Mar; 69(3):170-9. PubMed ID: 17441903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
    Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
    Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel azapeptide inhibitors of hepatitis C virus serine protease.
    Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
    J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
    Meara JP; Rich DH
    J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease.
    Venkatraman S; Kong J; Nimkar S; Wang QM; Aubé J; Hanzlik RP
    Bioorg Med Chem Lett; 1999 Feb; 9(4):577-80. PubMed ID: 10098667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
    Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
    Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of papain with 2-benzyl-3,4-epoxybutanoic acid esters. Mechanistic and stereochemical probe for cysteine protease catalysis.
    Kim DH; Jin Y; Ryu CH
    Bioorg Med Chem; 1997 Nov; 5(11):2103-8. PubMed ID: 9416427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.